Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alkermes (ALKS) Common Equity (2016 - 2025)

Alkermes (ALKS) has disclosed Common Equity for 16 consecutive years, with $1.8 billion as the latest value for Q4 2025.

  • Quarterly Common Equity rose 24.19% to $1.8 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.8 billion through Dec 2025, up 24.19% year-over-year, with the annual reading at $1.8 billion for FY2025, 24.19% up from the prior year.
  • Common Equity for Q4 2025 was $1.8 billion at Alkermes, up from $1.7 billion in the prior quarter.
  • The five-year high for Common Equity was $1.8 billion in Q4 2025, with the low at $1.0 billion in Q1 2023.
  • Average Common Equity over 5 years is $1.3 billion, with a median of $1.2 billion recorded in 2023.
  • The sharpest move saw Common Equity decreased 6.49% in 2023, then skyrocketed 34.16% in 2025.
  • Over 5 years, Common Equity stood at $1.1 billion in 2021, then dropped by 6.19% to $1.0 billion in 2022, then grew by 15.23% to $1.2 billion in 2023, then rose by 21.81% to $1.5 billion in 2024, then rose by 24.19% to $1.8 billion in 2025.
  • According to Business Quant data, Common Equity over the past three periods came in at $1.8 billion, $1.7 billion, and $1.6 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.